Norris Medicines Current Share Price | Norris Medicines Stock Screener
NORRIS
Trading & Distributors
Norris Medicines Current Stock Price Today
Live Share Price BSE
₹16.34
▲
0.76 (4.88%)
As of August 18, 2026, the live Norris Medicines share price (BSE: NORRIS) is ₹16.34, up 4.88% from the previous close, with shares trading between ₹15.50 and ₹16.35 in today's trading session, and a 52-week range of ₹12.31–₹18.68.
Analyse NORRIS share price history and track historical price performance.
Use the Norris Medicines stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Norris Medicines Market Cap
₹15.90 Cr.
NORRIS P/E Ratio (TTM)
-56.79
Norris Medicines P/B Ratio
-1.06
EPS (TTM)
₹-0.28
Dividend Yield
-
Debt to Equity
-
NORRIS 52 Week High
₹18.68
Norris Medicines 52 Week Low
₹12.31
Operating Margin
-1.00%
Profit Margin
-
NORRIS Revenue (TTM)
₹8.00
EBITDA
-
Net Income
-
Total Assets
₹14.00
Total Equity
₹-15.00
Norris Medicines Current Share Price Chart
Track the current Norris Medicines share price and stock price with an interactive chart. Analyse NORRIS price trends, trading volume, historical performance, and volatility across different timeframes — the complete Norris Medicines stock quote in one place.
Norris Medicines Company Profile - Fundamental Screener
Screen Norris Medicines company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NORRIS shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE744C01029
Norris Medicines Balance Sheet Screener
Screen NORRIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 |
| Current Assets | 6 | 6 | 5 | 4 | 8 | 7 | 7 | 8 | 9 | 7 |
| Fixed Assets | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 8 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 19 | 19 | 18 | 18 | 16 | 15 | 11 | 8 | 8 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -15 | -14 | -12 | -11 | -7 | -3 | 0 | 2 | 5 | 5 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -25 | -24 | -22 | -21 | -17 | -12 | -10 | -8 | -5 | -5 |
Norris Medicines Income Statement Screener - Profit & Revenue Analysis
Screen Norris Medicines income statement and profit fundamentals.
Analyze NORRIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Norris Medicines share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 8 | 6 | 6 | 8 | 10 | 12 | 8 | 16 | 14 | 21 | 19 | 19 |
| Expenses | 7 | 7 | 6 | 6 | 7 | 10 | 14 | 10 | 17 | 16 | 21 | 18 | 17 |
| EBITDA | 0 | 1 | 0 | 0 | 1 | 0 | -2 | -2 | -1 | -2 | 0 | 1 | 2 |
| Operating Profit % | -1.00% | 8.00% | -5.00% | -3.00% | 11.00% | -1.00% | -14.00% | -27.00% | -4.00% | -14.00% | 0.00% | 4.00% | 9.00% |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 0 | -1 | -1 | -1 | -2 | -4 | -4 | -2 | -3 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | -1 | -1 | -2 | -3 | -5 | -3 | -2 | -3 | -1 | 0 | -1 |
| EPS | -0.40 | -0.28 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
Norris Medicines Cash Flow Screener - Liquidity Fundamentals
Screen NORRIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 1 | -1 | 1 | -3 | -2 | 1 | -1 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 |
| Financing Activities | -1 | 0 | -1 | 1 | -1 | 3 | 2 | -1 | 3 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Norris Medicines Shareholding Pattern Screener
See Norris Medicines shareholding pattern with promoter, FII, and DII holdings.
Check Norris Medicines promoter holding and ownership changes for NORRIS on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 34.01% | 34.01% | 34.00% | 34.00% | 34.00% | 34.00% | 34.01% | 34.01% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.78% | 20.78% | 20.76% | 20.78% | 20.79% | 20.79% | 20.70% | 20.71% |
| Other Holding | 45.14% | 45.14% | 45.17% | 45.15% | 45.14% | 45.14% | 45.22% | 45.21% |
| Shareholder Count | 25,777 | 25,777 | 25,815 | 25,950 | 25,895 | 25,791 | 25,517 | 25,400 |
Norris Medicines Share Dividend Screener - Share Yield Analysis
Check Norris Medicines dividend history with payout and yield data.
View Norris Medicines dividend details including ex-dates and amounts for NORRIS stock.
Norris Medicines Stock Index Membership
See which indices include Norris Medicines stock.
Check NORRIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Norris Medicines Market Events Screener - Corporate Actions
Get Norris Medicines corporate actions including splits, bonuses, and buybacks.
Check Norris Medicines stock events that may affect NORRIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 9.39% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 1.92% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 2.57% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.42% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 3.69% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.16% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 6.26% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.88% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 15.67% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.97% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 66.24% |
| 2023-12-14 | 2023-12-14 | Annual General Meeting | NA | 9.29% |
Norris Medicines Competitors Screener - Peer Comparison
Screen NORRIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 26,115 | 17.33 | 119,347 | 19.87% | 1,284 | 61.35 |
| MMTC | 9,653 | 21.58 | 1 | -99.46% | 550 | 51.68 |
| MSTC | 4,389 | 18.70 | 370 | -4.60% | 221 | 54.44 |
| Ravindra Energy | 3,270 | 40.63 | 543 | 107.17% | 84 | 44.48 |
| Elitecon International | 2,745 | 8.16 | 551 | 55040.00% | 70 | 37.35 |
| BN Agrochem | 2,395 | 140.17 | 873 | 137.82% | 17 | 29.87 |
| Vintage Coffee & Beverages | 2,157 | 27.41 | 553 | 76.98% | 72 | 43.45 |
| Creative Newtech | 1,867 | 25.34 | 2,700 | 49.86% | 70 | 76.47 |
| TCC Concept | 1,234 | 18.22 | 179 | 100.21% | 31 | 34.56 |
| The Yamuna Syndicate | 929 | 10.18 | 72 | 6.07% | 52 | 66.30 |
Norris Medicines Company Announcements - News Screener
Screen NORRIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-18 | Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-18 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 14 2026 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-12 | Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-30 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026. | - |
| 2026-07-03 | Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-30 | Outcome Of Board Meeting Held Today I.E. 30Th May 2026. | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th May 2026. | - |
| 2026-05-25 | Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) 2015 For Holding Board Meeting For Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Other Matters. | - |
| 2026-04-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-02-14 | Outcome Of The Board Meeting Held On 14Th February 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-13 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Closure Of Case ID 223728 For Reclassification Of Promoter. | - |
| 2026-02-11 | Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31St 2025 And Oth | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |